Low molecular weight heparin as an alternative to unfractionated heparin in the immediate postoperative period after left ventricular assist device implantation

Artificial Organs

Volumn 32, Issue 10, 2008, Pages 819-822

  Sandner, Sigrid E ^a   Zimpfer, Daniel ^a   Zrunek, Philipp ^a   Steinlechner, Barbara ^a   Rajek, Angela ^a   Schima, Heinrich ^a   Wolner, Ernst ^a   Wieselthaler, Georg M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anticoagulation; Bridge to transplantation; Left ventricular assist device; Low molecular weight heparin; Unfractionated heparin

Indexed keywords

FIBER OPTIC SENSORS; MOLECULAR WEIGHT; POLYSACCHARIDES;

ANTI-COAGULATION; ANTIPLATELETS THERAPY; BLEEDINGS; BRIDGE TO TRANSPLANTATION; DIPYRIDAMOLE; FACTOR XA; HEART FAILURE; HEART TRANSPLANTATION; LOW-MOLECULAR WEIGHT HEPARINS; UNFRACTIONATED HEPARINS;

LEFT VENTRICULAR ASSIST DEVICES;

ACETYLSALICYLIC ACID; ALTEPLASE; DIPYRIDAMOLE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; PHENPROCOUMON; SERUM ALBUMIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; ASSISTED CIRCULATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTINUOUS INFUSION; CONTROLLED STUDY; HEART ASSIST DEVICE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

EID: 54849431184     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2008.00634.x     Document Type: Article

References (9)

1. Hirsh J, O'Donnell M, Eikelboom JW. Beyond unfractionated heparin and warfarin: current and future advances. Circulation 2007 116 : 552 60.
2. Vermes E, Kirsch M, Farrokhi T, et al. Management of intracranial hemorrhage in patients with mechanical circulatory support: a role for low-molecular-weight heparins? ASAIO J 2005 51 : 485 6.
3. Ghez O, Liesner R, Karimova A, Ng C, Goldman A, van Doorn C. Subcutaneous low molecular weight heparin for management of anticoagulation in infants on Excor ventricular assist device. ASAIO J 2006 52 : 705 7.
4. Meuris B, Arnout J, Vlasselaers D, Schetz M, Meyns B. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants. Artif Organs 2007 31 : 402 5.
5. Murphy SA, Gibson CM, Morrow DA, et al. Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis. Eur Heart J 2007 28 : 2077 86.
6. Snow V, Qaseem A, Barry P, et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2007 146 : 204 10.
7. Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000 101 : 1083 6.
8. Fanikos J, Tsilimingras K, Kucher N, Rosen AB, Hieblinger MD, Goldhaber SZ. Comparison of efficacy, safety, and cost of low-molecular-weight heparin with continuous-infusion unfractionated heparin for initiation of anticoagulation after mechanical prosthetic valve implantation. Am J Cardiol 2004 93 : 247 50.
9. Kulik A, Rubens FD, Wells PS, et al. Early postoperative anticoagulation after mechanical valve replacement: a systematic review. Ann Thorac Surg 2006 81 : 770 81.